Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43412-3
- By:
- Publication type:
- Article
Works by Mockeliunas, Laurynas
Results: 8
1
2
Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43412-3
- By:
- Publication type:
- Article
3
Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1150243
- By:
- Publication type:
- Article
4
Seasonal influence on respiratory tract infection severity including COVID‐19 quantified through Markov Chain modeling.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 9, p. 1250, doi. 10.1002/psp4.13006
- By:
- Publication type:
- Article
5
Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/pharmaceutics14040753
- By:
- Publication type:
- Article
6
Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 11, p. 1575, doi. 10.3390/ph16111575
- By:
- Publication type:
- Article
7
Response of Tradescantia plants to oxidative stress induced by heavy metal pollution of soils from industrial areas.
- Published in:
- Environmental Science & Pollution Research, 2019, v. 26, n. 1, p. 44, doi. 10.1007/s11356-018-3224-3
- By:
- Publication type:
- Article
8
Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic.
- Published in:
- Vaccines, 2024, v. 12, n. 3, p. 329, doi. 10.3390/vaccines12030329
- By:
- Publication type:
- Article